Barclays’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $591M | Sell |
1,248,315
-73,896
| -6% | -$37.2M | 0.14% | 110 |
|
|
2025
Q4 | $617M | Buy |
1,322,211
+91,319
| +7% | +$42.4M | 0.15% | 97 |
|
|
2025
Q3 | $525M | Sell |
1,230,892
-29,893
| -2% | -$11.6M | 0.11% | 118 |
|
|
2025
Q2 | $483M | Buy |
1,260,785
+24,318
| +2% | +$8.76M | 0.11% | 116 |
|
|
2025
Q1 | $427M | Buy |
1,236,467
+174,576
| +16% | +$56.1M | 0.12% | 129 |
|
|
2024
Q4 | $319M | Buy |
1,061,891
+489,916
| +86% | +$171M | 0.09% | 147 |
|
|
2024
Q3 | $232M | Buy |
571,975
+104,409
| +22% | +$38.2M | 0.06% | 223 |
|
|
2024
Q2 | $150M | Sell |
467,566
-52,207
| -10% | -$17M | 0.05% | 291 |
|
|
2024
Q1 | $173M | Buy |
519,773
+24,843
| +5% | +$7.59M | 0.06% | 260 |
|
|
2023
Q4 | $134M | Sell |
494,930
-58,668
| -11% | -$14.5M | 0.05% | 325 |
|
|
2023
Q3 | $136M | Buy |
553,598
+109,592
| +25% | +$30M | 0.08% | 233 |
|
|
2023
Q2 | $135M | Buy |
444,006
+255,704
| +136% | +$71.1M | 0.09% | 208 |
|
|
2023
Q1 | $49.7M | Sell |
188,302
-233,805
| -55% | -$59.4M | 0.02% | 465 |
|
|
2022
Q4 | $101M | Buy |
422,107
+83,583
| +25% | +$18.7M | 0.05% | 273 |
|
|
2022
Q3 | $62.2M | Buy |
338,524
+53,137
| +19% | +$10.6M | 0.07% | 259 |
|
|
2022
Q2 | $48M | Sell |
285,387
-108,466
| -28% | -$23.3M | 0.03% | 417 |
|
|
2022
Q1 | $98.7M | Sell |
393,853
-264,928
| -40% | -$66.5M | 0.08% | 238 |
|
|
2021
Q4 | $169M | Buy |
658,781
+1,835
| +0.3% | +$449K | 0.06% | 241 |
|
|
2021
Q3 | $159M | Buy |
656,946
+41,779
| +7% | +$10.2M | 0.07% | 224 |
|
|
2021
Q2 | $127M | Buy |
615,167
+27,424
| +5% | +$5.59M | 0.06% | 248 |
|
|
2021
Q1 | $111M | Buy |
587,743
+194,856
| +50% | +$34.4M | 0.06% | 240 |
|
|
2020
Q4 | $64.6M | Buy |
392,887
+113,776
| +41% | +$16.6M | 0.03% | 371 |
|
|
2020
Q3 | $34.8M | Buy |
279,111
+68,897
| +33% | +$8.53M | 0.02% | 508 |
|
|
2020
Q2 | $20.4M | Sell |
210,214
-6,026
| -3% | -$626K | 0.02% | 637 |
|
|
2020
Q1 | $19.4M | Sell |
216,240
-193,244
| -47% | -$25M | 0.02% | 654 |
|
|
2019
Q4 | $60.5M | Sell |
409,484
-177,576
| -30% | -$23.8M | 0.03% | 427 |
|
|
2019
Q3 | $70.7M | Sell |
587,060
-241,348
| -29% | -$31.2M | 0.04% | 343 |
|
|
2019
Q2 | $112M | Buy |
828,408
+295,331
| +55% | +$37.3M | 0.07% | 234 |
|
|
2019
Q1 | $69.5M | Buy |
533,077
+102,729
| +24% | +$13.8M | 0.05% | 344 |
|
|
2018
Q4 | $53.6M | Buy |
430,348
+9,384
| +2% | +$1.26M | 0.04% | 359 |
|
|
2018
Q3 | $58.6M | Sell |
420,964
-34,642
| -8% | -$4.31M | 0.04% | 356 |
|
|
2018
Q2 | $46.7M | Sell |
455,606
-125,885
| -22% | -$12.7M | 0.04% | 383 |
|
|
2018
Q1 | $56.4M | Sell |
581,491
-253,937
| -30% | -$24.6M | 0.04% | 379 |
|
|
2017
Q4 | $73.4M | Sell |
835,428
-698,840
| -46% | -$56.1M | 0.06% | 266 |
|
|
2017
Q3 | $122M | Buy |
1,534,268
+352,267
| +30% | +$28.3M | 0.13% | 131 |
|
|
2017
Q2 | $103M | Buy |
1,182,001
+470,155
| +66% | +$39.8M | 0.11% | 139 |
|
|
2017
Q1 | $63.3M | Sell |
711,846
-270,145
| -28% | -$22.5M | 0.07% | 206 |
|
|
2016
Q4 | $72.7M | Sell |
981,991
-11,180
| -1% | -$837K | 0.08% | 196 |
|
|
2016
Q3 | $75.1M | Buy |
993,171
+170,090
| +21% | +$13M | 0.08% | 179 |
|
|
2016
Q2 | $63.4M | Buy |
823,081
+148,758
| +22% | +$11.7M | 0.08% | 205 |
|
|
2016
Q1 | $52.6M | Sell |
674,323
-137,018
| -17% | -$9.57M | 0.08% | 202 |
|
|
2015
Q4 | $54.4M | Buy |
811,341
+416,601
| +106% | +$29.1M | 0.07% | 252 |
|
|
2015
Q3 | $30.4M | Buy |
394,740
+133,533
| +51% | +$11.8M | 0.04% | 421 |
|
|
2015
Q2 | $23.5M | Sell |
261,207
-196,980
| -43% | -$15.8M | 0.03% | 579 |
|
|
2015
Q1 | $34.4M | Buy |
458,187
+302,316
| +194% | +$21.7M | 0.04% | 444 |
|
|
2014
Q4 | $11.4M | Sell |
155,871
-241,340
| -61% | -$17M | 0.01% | 1097 |
|
|
2014
Q3 | $27.8M | Buy |
397,211
+209,774
| +112% | +$13.9M | 0.03% | 557 |
|
|
2014
Q2 | $10.5M | Sell |
187,437
-89,059
| -32% | -$4.7M | 0.01% | 1124 |
|
|
2014
Q1 | $14.4M | Sell |
276,496
-71,195
| -20% | -$3.54M | 0.02% | 896 |
|
|
2013
Q4 | $16.3M | Sell |
347,691
-27,023
| -7% | -$1.25M | 0.02% | 891 |
|
|
2013
Q3 | $15.7M | Sell |
374,714
-8,488
| -2% | -$332K | 0.02% | 824 |
|
|
2013
Q2 | $13.8M | Buy |
+383,202
| New | +$14.8M | 0.02% | 855 |
|
Other funds holding HCA
VCM
VPM
Barclays's HCA Position: Q1 2026 in Review
Barclays reduced its HCA Healthcare (HCA) stake by 5.6% in Q1 2026, selling an estimated $37.2M and leaving 1,248,315 shares worth $591M. The position accounts for 0.14% of the portfolio, ranked #110.
Barclays first reported a position in HCA in Q2 2013 and has held it in 52 quarters since. The position peaked at $617M in Q4 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Barclays held 1,248,315 shares of HCA Healthcare worth $591M as of Q1 2026.
- Barclays sold 73,896 HCA Healthcare shares in Q1 2026, an estimated $37.2M.
- HCA Healthcare made up 0.14% of Barclays's portfolio in Q1 2026, its #110 holding.
- Barclays first reported a position in HCA Healthcare in Q2 2013 and has held it in 52 quarters since.
- Barclays's HCA Healthcare position peaked at $617M in Q4 2025.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.